SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-024215
Filing Date
2015-03-31
Accepted
2015-03-31 07:15:22
Documents
3
Period of Report
2015-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-8230_18k.htm 8-K 30376
2 EX-99.1 a15-8230_1ex99d1.htm EX-99.1 99996
3 GRAPHIC g82301mm01i001.gif GRAPHIC 1481
  Complete submission text file 0001104659-15-024215.txt   133890
Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034
Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000
Vitae Pharmaceuticals, Inc (Filer) CIK: 0001157602 (see all company filings)

IRS No.: 043567753 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36617 | Film No.: 15736408
SIC: 2834 Pharmaceutical Preparations